Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.07 Analyst target: $19.67 Upside: 540.72%
Nasus Pharma Ltd. is a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company is headquartered in Tel Aviv-Yafo, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.